Micafungin as a prophylactic antifungal during induction phase of chemotherapy for pediatric acute lymphoblastic leukemia / Afaf Mohammad Mahmoud ; Supervised Lobna Mohamed Shalaby , Hadir Ahmad Elmahallawy , Sahar Ahmad Khalil
Material type: TextLanguage: English Publication details: Cairo : Afaf Mohammad Mahmoud , 2016Description: 89 P. ; 25cmOther title:- للوقاية من الاصابة بالفطريات خلال الفترة التحفيزية من علاج سرطان الدم الليمفاوى الحاد فى الاطفال Micafungin استخدام عقار المايكافنجين [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.05.M.Sc.2016.Af.M (Browse shelf(Opens below)) | Not for loan | 01010110069713000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.05.M.Sc.2016.Af.M (Browse shelf(Opens below)) | 69713.CD | Not for loan | 01020110069713000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology
Background: Invasive fungal infection (IFI) remains a major cause of infectious morbidity and mortality in neutropenic patients receiving chemotherapy or hematopoietic stem cell transplantation (HSCT). Micafungin exhibits broad antifungal activity against both Aspergillus and Candida species. Objective: We performed a prospective study to determine the efficacy, safety, and tolerability of prophylactic micafungin against IFI in pediatric neutropenic patients during induction chemotherapy for acute lymphoblastic leukemia (ALL). Results: Treatment success rate, defined as absence of proven, probable, or possible IFIs, was 75%. No adverse events were observed that could be related to micafungin prophylaxis. Conclusions: These results suggest that prophylactic micafungin is well tolerated and may prevent IFIs in pediatric patients with neutropenia receiving chemotherapy
Issued also as CD
There are no comments on this title.